BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 38310162)

  • 1. Obesity-associated epigenetic alterations and the obesity-breast cancer axis.
    Lagarde CB; Kavalakatt J; Benz MC; Hawes ML; Arbogast CA; Cullen NM; McConnell EC; Rinderle C; Hebert KL; Khosla M; Belgodere JA; Hoang VT; Collins-Burow BM; Bunnell BA; Burow ME; Alahari SK
    Oncogene; 2024 Mar; 43(11):763-775. PubMed ID: 38310162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
    Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
    Oh S; Ko JY; Oh C; Yoo KH
    Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
    Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
    J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in breast cancer: what's new?
    Huang Y; Nayak S; Jankowitz R; Davidson NE; Oesterreich S
    Breast Cancer Res; 2011; 13(6):225. PubMed ID: 22078060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenetics of breast cancer.
    Jovanovic J; Rønneberg JA; Tost J; Kristensen V
    Mol Oncol; 2010 Jun; 4(3):242-54. PubMed ID: 20627830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and the breast cancer methylome.
    Coleman WB
    Curr Opin Pharmacol; 2016 Dec; 31():104-113. PubMed ID: 27886642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
    Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
    Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.
    Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E
    Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression.
    Santos GC; da Silva AP; Feldman L; Ventura GM; Vassetzky Y; de Moura Gallo CV
    J Cell Biochem; 2015 Apr; 116(4):533-41. PubMed ID: 25358520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
    Zhang J; Huang L; Ge G; Hu K
    Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
    Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B
    Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer.
    Sarvari P; Sarvari P; Ramírez-Díaz I; Mahjoubi F; Rubio K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes.
    Matei D; Nephew KP
    Cancer Res; 2020 Sep; 80(18):3775-3785. PubMed ID: 32381656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Kar S; Patra SK
    Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of epigenetics in breast cancer - A review.
    Bhat SA; Majid S; Wani HA; Rashid S
    Cancer Treat Res Commun; 2019; 19():100125. PubMed ID: 30802811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomics of mammary gland development.
    Holliday H; Baker LA; Junankar SR; Clark SJ; Swarbrick A
    Breast Cancer Res; 2018 Sep; 20(1):100. PubMed ID: 30176939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.